News

Costco December comp sales up 3% with strong performance from pharmacy division

BY Michael Johnsen

ISSAQUAH, Wash.  – Costco Wholesale Corporation on Wednesday reported net sales of $12.5 billion for the month of December, which includes the five weeks ended Jan. 3, 2016, an increase of 3%.
 
For the 18 weeks ended Jan. 3, 2016, the company reported net sales of $41.7 billion, an increase of 2%.
 
Comparable sales across Costco's U.S. network were up 3% across both time frames.
 
Comparable results were best among the company's hearing aid, optical and pharmacy categories, Jeff Elliott, AVP financial planning and investor relations, shared in a pre-recorded call for investors. Comparable sales of fresh food was up in the mid single digits and across food and sundries in the low to mid single digits, Elliott reported. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Lupin launches generic Ortho Tri-Cyclen Lo

BY DSN STAFF

MUMBAI and BALTIMORE — Lupin Pharmaceuticals announced Wednesday that it had launched its Tri-Lo-Marzia (norgestimate and ethinyl estradiol) tablets, a generic version of Jannsen’s Ortho Tri-Cyclen Lo. The drug is indicated to prevent pregnancy in women. 
 
Ortho Tri-Cyclen Lo saw about $488.4 million in sales in the 12 months ending September 2015, according to IMS Health. This is Lupin’s 16th contraceptive launch in the United States. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Jean Coutu Q3 sales up 1.7%

BY Michael Johnsen

VARENNES, Québec — The Jean Coutu Group reported Thursday revenues of $530.3 million for the third quarter ended Nov. 28, 2015, up 1.7%.
 
Jean Coutu Group attributed the increase to the overall market growth despite the deflationary impact of generic drugs. Generic drugs reached 69.8% of prescriptions during the third quarter of fiscal year 2016 compared with 68.1% of prescriptions for the comparable period of the previous fiscal year.
 
“We are satisfied with the results of the third quarter of fiscal 2016, which demonstrate the relevance of our strategies and the strength of our organization, despite the restrictive regulatory context which prevails in our industry," stated François Coutu, president and CEO Jean Coutu Group. “In the next few months, we will continue to capitalize on dynamic strategic initiatives to maintain our growth and sustain our leadership.” 
 
On a same-store basis, the Jean Coutu Group network's retail sales increased by 0.1%, pharmacy sales decreased by 1.6% and front-end sales increased by 2.4%, compared with the corresponding period last year. Sales of non-prescription drugs, which represented 9.1% of total retail sales, increased by 3.9% compared with 1.6% for the corresponding period of fiscal year 2015.
 
During the third quarter of fiscal year 2016, there was one franchised store relocated and one store was closed. Also, three stores were significantly renovated or expanded.
 
As at Nov. 28, 2015, total selling square footage of the Jean Coutu Group network amounted to 3.2 million square feet, up 1.6%.
 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?